Loading...
•
Mar 31, 2022
Bausch Health Q1 2022 Earnings Report
Bausch Health reported a revenue of $1.918 billion and a net loss of $69 million.
Key Takeaways
Bausch Health Companies Inc. announced its first-quarter 2022 financial results. The company reported revenues of $1.918 billion and a GAAP net loss of $69 million. Adjusted EBITDA was $732 million. Bausch + Lomb commenced trading under the ticker "BLCO" following its IPO.
Revenues of $1.918 Billion
GAAP Net Loss of $69 Million
Adjusted EBITDA (non-GAAP) of $732 Million
Bausch + Lomb Commenced Trading Under “BLCO” Ticker Following IPO
Bausch Health
Bausch Health
Bausch Health Revenue by Segment
Revenue by Segment
Bausch + Lomb/International Revenue
CapyFin.comSalix Revenue
CapyFin.comDiversified Products Revenue
CapyFin.com Forward Guidance
Bausch Health updated its guidance for the full year of 2022 as follows: Full-Year revenue range of $8.25 – $8.40 billion, reaffirming organic growth of 3 – 5%. Full-Year Adjusted EBITDA (non-GAAP) range of $3.225 – $3.375 billion, including $100 million of the previously disclosed $150 million annual run rate of dis-synergies
Revenue & Expenses
Visualization of income flow from segment revenue to net income